SCHEMBL18173435

SCHEMBL18173435

CC(C)(C[CH]C1CCNCC1)CC(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 1/20 0.40
CPT2 P23786 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
KDM4E B2RXH2 1/20 0.36
GABRA5 P31644 3/20 0.34
GABRB2 P47870 3/20 0.34
TSHR P16473 3/20 0.34
GABRA1 P14867 2/20 0.34
GABRA4 P48169 2/20 0.34
GABRP O00591 1/20 0.34
GABRD O14764 1/20 0.34
GABRB1 P18505 1/20 0.34
GABRG2 P18507 1/20 0.34
GABRB3 P28472 1/20 0.34
GABRA3 P34903 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRE P78334 1/20 0.34
PMP22 Q01453 1/20 0.34
GABRA6 Q16445 1/20 0.34
GABRG1 Q8N1C3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18173065 0.74 ALDH1A1 (0.31)
SCHEMBL6231034 0.74
SCHEMBL18173431 0.72 GABRA5 (0.43) GABRA5GABRB2TSHRGABRA1GABRA4
SCHEMBL18172786 0.71 ACLY (0.41) GABRA5GABRB2TSHRGABRA1GABRA4
SCHEMBL18172659 0.69 GABRA5 (0.40) GABRA5GABRB2TSHRGABRA1GABRA4
SCHEMBL29106934 0.66 FFAR1 (0.36) FFAR1CPT2TDP1KDM4EGABRA5
SCHEMBL1954515 0.65 KDM4E (0.50) FFAR1CPT2TDP1KDM4ETSHR
SCHEMBL2999282 0.64 FFAR1 (0.75) FFAR1CPT2TDP1KDM4ETSHR
SCHEMBL2044485 0.64 KDM4E (0.48) FFAR1CPT2TDP1KDM4ETSHR
SCHEMBL48109 0.63 KDM4E (0.65) FFAR1CPT2TDP1KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286172-A1 LSD1 INHIBITORS AND USES THEREOF Constellation Pharmaceuticals, Inc. (US) 2018-02-28 EP claimed
WO-2016172496-A1 LSD1 INHIBITORS AND USES THEREOF CONSTELLATION PHARMACEUTICALS, INC. (US) 2016-10-27 WO claimed